Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
XB-ART-8409
Proc Natl Acad Sci U S A 2001 Sep 25;9820:11545-50. doi: 10.1073/pnas.191112198.
Show Gene links Show Anatomy links

Immunogene therapy of tumors with vaccine based on Xenopus homologous vascular endothelial growth factor as a model antigen.

Wei YQ , Huang MJ , Yang L , Zhao X , Tian L , Lu Y , Shu JM , Lu CJ , Niu T , Kang B , Mao YQ , Liu F , Wen YJ , Lei S , Luo F , Zhou LQ , Peng F , Jiang Y , Liu JY , Zhou H , Wang QR , He QM , Xiao F , Lou YY , Xie XJ , Li Q , Wu Y , Ding ZY , Hu B , Hu M , Zhang W .


???displayArticle.abstract???
Overcoming immune tolerance of the growth factors associated with tumor growth should be a useful approach to cancer therapy by active immunity. We used vascular endothelial growth factor (VEGF) as a model antigen to explore the feasibility of the immunogene tumor therapy with a vaccine based on a single xenogeneic homologous gene, targeting the growth factors associated with angiogenesis. To test this concept, we constructed a plasmid DNA encoding Xenopus homologous VEGF (XVEGF-p) and control vectors. We found that immunogene tumor therapy with a vaccine based on XVEGF was effective at both protective and therapeutic antitumor immunity in several tumor models in mice. VEGF-specific autoantibodies in sera of mice immunized with XVEGF-p could be found in Western blotting analysis and ELISA assay. The purified immunoglobulins were effective at the inhibition of VEGF-mediated endothelial cell proliferation in vitro, and at antitumor activity and the inhibition of angiogenesis by adoptive transfer in vivo. The elevation of VEGF in the sera of the tumor-bearing mice could be abrogated with XVEGF-p immunization. The antitumor activity and production of VEGF-specific autoantibodies, significantly elevated IgG1 and IgG2b, could be abrogated by the depletion of CD4(+) T lymphocytes. The observations may provide a vaccine strategy for cancer therapy through the induction of autoimmunity against the growth factors associated with tumor growth in a cross reaction with single xenogeneic homologous gene and may be of importance in the further exploration of the applications of other xenogeneic homologous genes identified in human and other animal genome sequence projects in cancer therapy.

???displayArticle.pubmedLink??? 11553767
???displayArticle.pmcLink??? PMC58766
???displayArticle.link??? Proc Natl Acad Sci U S A


Species referenced: Xenopus laevis
Genes referenced: areg vegfa

References [+] :
Amagai, Antibodies against desmoglein 3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal mice. 1998, Pubmed